Sun Pharma Advanced Research Company reports consolidated net loss of Rs 51.87 crore in the June 2025 quarter
Sales decline 42.65% to Rs 9.64 crore
Net Loss of Sun Pharma Advanced Research Company reported to Rs 51.87 crore in the quarter ended June 2025 as against net loss of Rs 95.90 crore during the previous quarter ended June 2024. Sales declined 42.65% to Rs 9.64 crore in the quarter ended June 2025 as against Rs 16.81 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales9.6416.81 -43 OPM %-540.25-555.38 -PBDT-49.13-92.36 47 PBT-51.81-95.50 46 NP-51.87-95.90 46Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content